What’s almost never mentioned is that VPA-glucuronide is metabolized *back* to VPA
This is done by an enzyme called acylpeptide hydrolase (APEH)
APEH just removes the glucuronide moiety (blue), leaving us with good old VPA
/6
This puzzling interaction was explained in 2010 by scientists in Japan, who purified what was then called “VPA-glucuronide hydrolase” from human liver
First they identified it as APEH
Then they showed it was inhibited by panipenem
/7
In a way, APEH is just another enzyme inhibited by carbapenems. This is how they work.
They acylate penicillin binding proteins (PBPs)—transpeptidases, carboxypeptidases, etc.—involved in the synthesis of peptidoglycan, the major component of bacterial cell walls.
/8
Worth noting that all carbapenems lower [VPA], although imipenem might do so to a lesser extent
And the interaction isn’t easily overcome by a higher dose of VPA
This report of a physician who died after receiving COVID vaccine offers a useful lesson in the importance of thinking more critically about does and what does not constitute a drug reaction.
/1 usatoday.com/story/news/hea…
Briefly, the MD noticed petechiae (tiny areas of bleeding into the skin, as seen in image) 3 days after vaccination. He was diagnosed with ITP (immune thrombocytopenic purpura).
People with ITP have profoundly low platelets and can bleed spontaneously as a result.
/2
The temptation to blame the vaccine is understandable: we’re hypervigilant about the safety of new drugs (especially high-profile ones employing a novel technology), and the timing seems like a slam dunk.